Malnutrition could be a hidden culprit that lowers quality of life for people with larger bodies, especially if they have a health condition like osteoarthritis, University of Alberta research has ...

Among participants with obesity and knee osteoarthritis with moderate-to-severe pain, treatment with once-weekly injectable semaglutide resulted in significantly greater reductions in body weight ...

A large trial showed that semaglutide, sold as Ozempic for diabetes and as Wegovy for obesity, was better than any current medications in alleviating symptoms.

Individuals with vs without knee, hip, or hand OA were associated with a significantly increased risk for sleep apnea.

The Association of Body-Mass Index and Depressed Mood With Knee Pain and Activity Limitations in Knee Osteoarthritis Results From the Amsterdam Osteoarthritis Cohort ...

A new study shows that Ozempic may help ease arthritis knee pain in people with obesity. Here's what to know about the study and whether semaglutide can truly help reduce knee pain, according to ...

The global prevalence of OA attributed to high BMI has steadily increased over the past 3 decades, particularly among women and in high-SDI regions.

Malnutrition could be a hidden culprit that lowers quality of life for people with larger bodies, especially if they have a health condition like ...

Background Patellofemoral pain (PFP) occurs frequently, and may be related to patellofemoral osteoarthritis (PFOA). Obesity is associated with increased risk of knee OA. This systematic review ...

Osteoarthritis cases and disability among postmenopausal women have risen significantly over the past three decades, driven by aging, obesity, and regional trends.